Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program

 

In accordance with section 1848(s)(6) of the Social Security Act, as added by section 102 of the Medicare Access and Children?s Health Insurance Program Reauthorization Act of 2015, this funding opportunity will be used for developing, improving, updating or expanding quality measures for use in the Quality Payment Program under the Merit-Based Incentive Payment System and/or Advanced Alternative Payment Models. Recognizing the benefits of measure development by external stakeholders with

Deleted 03/27/2024 (Archived.) 93.986 Centers For Medicare and Medicaid Services, Department of Health and Human Services A - Formula Grants; Z - Salaries and Expenses Fiscal Year 2016 N/A
Fiscal Year 2018 N/A
Fiscal Year 2017 The program is new. It is anticipated that 30 applications will be received and 5-10 awards will be granted in fiscal year 2018. Section 1848(s)(6) of the Social Security Act, as added by section 102 of the Medicare Access and Children’s Health Insurance Program Reauthorization Act of 2015. Clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, health systems, and other entities engaged in quality measure development. For this funding opportunity, the above categories are referenced collectively as entity or entities. The language, engaged in quality measure development, pertains to each of the above referenced entities. Entities must: 1) demonstrate, or partner with an organization with demonstrated, quality measure development expertise 2) be engaged in quality measure conceptualization, development, or evaluation 3) be involved in developing evidence-based clinical practice guidelines Otherwise eligible entities must not be actively receiving federal funding for quality measure development, implementation, maintenance, or public reporting activities for quality measures. However, such an entity may be a sub-recipient on one or multiple applications. Quality Payment Program provides new opportunities to improve care delivery by supporting and rewarding clinicians as they find new ways to engage patients, families, and caregivers and to improve care coordination and population health management. The quality measures in MIPS and APMs serve as the mechanism of measuring the improved care delivery. With this funding opportunity, CMS is engaging eligible entities to develop the quality measures as a way of enhancing the measure portfolio with additional measures for specialties. An enhanced measure portfolio helps to ensure that a higher percentage of providers can use quality measurement to improve their practice. This results in consumers making more informed decisions regarding their healthcare and overall health care quality improvements. The ultimate beneficiaries from this work are providers, consumers, healthcare stakeholders, and anyone interested in quality as the quality measures developed better reflect the complexity and diversity of our healthcare system and improve the quality of healthcare for everyone. Not applicable. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. N/A Successful applicants will receive a Notice of Award (NoA) signed and dated by the CMS Grants Management Officer that will set forth the amount of the award and other pertinent information. The award will also include standard Terms and Conditions, and may also include additional specific cooperative agreement terms and conditions. Potential applicants should be aware that special requirements could apply to cooperative agreement awards based on the particular circumstances of the effort to be supported and/or deficiencies identified in the application by the review panel. The NoA is the legal document issued to notify the awardee that an award has been made and that funds may be requested from the HHS payment system. The NoA will be sent electronically to the Authorized Official and awardee organization as listed Contact the headquarters or regional location, as appropriate for application deadlines Anticipated dates of awards for Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program is approximately 60 days after the application due date. Not applicable. Not applicable. Not applicable. Funds are to be used for measure development activities to provide for a fully developed measure suitable for use in the CMS Quality Payment Program. Funds may be used to secure technical measure development expertise with external (to the recipient) experts. Funds should be used in accordance with generally accepted measure development principles. Performance Reports: All awardees will be required to cooperate in providing the necessary information to CMS and/or a CMS contractor for ongoing performance monitoring. The contractor would assist CMS in developing appropriate monitoring protocols and tracking performance across awardees and providing for rapid cycle evaluation and early detection of performance problems, including coordination between awardees and CMS and its other contractors. Performance monitoring will include but is not limited to monthly calls with CMS and/or a CMS contractor. N/A Financial records, supporting documents, statistical records, and all other records pertinent to an award shall be retained by the grantee for a period of 3 years from the date of submission of the final SF-425 (FFR) except if any litigation, claim, financial management review, or audit is started before the expiration of the 3-year period, the records shall be retained until all litigation, claims or audit findings involving the records have been resolved and final action taken. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. The award is available for up to a 3-year project period comprised of 3 separate 12-month budget periods. Funding will be issued each year through a non-competing continuation award based upon a demonstration of progress. Applicants may apply for a 1, 2, or 3 year project period. Upon receiving a Notice of Award, recipients will receive money incrementally via, up to, three separate 12-month budget periods (also called non-competing continuation awards). Each year recipients will submit a progress report where they will be evaluated on their completion of the milestones. Funding will be issued each year through a non-competing continuation award based upon a demonstration of progress. None/Not specified. Wilfred Agbenyikey
7500 Security Boulevard
Woodlawn, MD 21244 US
Wilfred.Agbenyikey@cms.hhs.gov
Phone: 410-786-4399 http://www.cms.gov 75-0511-0-1-551 (Salaries and Expenses) FY 18$9,228,475.00; FY 19 est $8,529,320.00; FY 20 est $8,832,783.00; FY 17$0.00; FY 16$0.00; - N/A The Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program Cooperative Agreements expect to award 5-10 agreements with a range of $0-$2,000,000 a year for up to 3 years. The expected total funding is $10,000,000 a years for 3 years totaling $30,000,000. This is a new program with no financial assistance awards (dollars) that were made in the past and current fiscal years. Section 1848(s)(6) of the Social Security Act, as added by section 102 of the Medicare Access and Children's Health Insurance Program Reauthorization Act of 2015 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards 45 CFR 75, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards (HHS regulation implementing OMB regulation 2 CFR 200) Not applicable.